Behavioral Interventions for Weight Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people maintain weight loss using smartphone technology and behavioral strategies. Participants will receive a 6-month behavioral obesity treatment to lose weight. Those who lose at least 3% of their starting weight will undergo a year of monitoring through daily smartphone surveys to identify and address risks for weight gain. Known as Control Systems Engineering for Weight Loss Maintenance, this approach suits English speakers who can walk two city blocks without stopping, have a BMI between 25 and 50, and own a smartphone. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to innovative weight loss maintenance strategies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking weight loss medication.
What prior data suggests that this behavioral intervention is safe for weight loss?
Research shows that using technology to aid weight loss is generally safe and well-received. Studies have found that computer-based tools, such as apps or programs, can assist with losing weight and maintaining it without major safety issues. These tools often track habits and provide feedback.
Participants who used technology alongside regular weight loss programs experienced better short-term results. No serious side effects were reported in these studies, suggesting that this approach is safe for most people. However, discussing any concerns with a healthcare provider before joining a trial is always important.12345Why are researchers excited about this trial?
Unlike standard treatments for weight loss, which often focus on dietary changes, exercise, or medication, the investigational approach in this trial uses control systems engineering for weight loss maintenance. This method involves a unique "system identification" experiment, where participants who lose at least 3% of their initial body weight engage in daily monitoring to better understand their physiological responses over a year. Researchers are excited about this because it could provide personalized strategies to maintain weight loss, potentially offering a more sustainable solution compared to traditional methods.
What evidence suggests that this behavioral intervention is effective for weight loss?
Studies have shown that technology in weight loss programs can help people maintain weight loss. For example, over 36% of participants using a mobile technology system lost at least 5% of their starting weight, while none in a regular care group did. Research also shows that online programs can help prevent weight gain after losing weight. In this trial, participants will engage in a system identification experiment, which uses behavior data to help maintain weight loss. This method predicts when someone might regain weight and addresses those risks, offering a promising tool for long-term success.12367
Are You a Good Fit for This Trial?
This trial is for individuals who are obese and have successfully lost at least 3% of their initial body weight. Participants should be willing to use a smartphone daily for surveys and passive sensing over a period of 12 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
A 6-month behavioral obesity treatment is administered to produce weight loss
System Identification Experiment
Participants who lose at least 3% of initial body weight are followed for 12 months with daily smartphone surveys and passive sensing to monitor behaviors
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Control Systems Engineering for Weight Loss Maintenance
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Miriam Hospital
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator